Modern coronavirus vaccine is on the right track- Clinical trial results published by the New England Journal of Medicine
“It certainly is a good beginning,” for vaccine Development for COVID-19.
The mRNA-1273 vaccine induced anti–SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified. These findings support further development of this vaccine.
So let’s be safe, till the vaccine will come out with good result from Phase 3 study.